| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 541929 | Synergy Green Synergy Green Industries Ltd | 19-May-2026 | Synergy Green Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve Intimation of Board meeting which will be held on 19.05.2026 to approve Audited Financial Results for FY 2025-26 and declaration of dividend. |
| 542057 | BCPL Railway BCPL Railway Infrastructure Ltd | 19-May-2026 | Final Dividend & Audited Results BCPL Railway Infrastructure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve 1. Audited Financial Statements standalone and consolidated for the quarter and financial year ended March 31, 2026. 2. Recommending Final Dividend, if any. 3. Recommending reappointment of Mr Ranajit Mondal (DIN: 06430495) with effect from 14.08.2026 to function as Independent Directors for a term of 5 years. 4. Recommending reappointment of M/s L B Jha & Co. as the Statutory Auditors of the Company for a period of 5 years subject to approval of the shareholders. 5. Considering issues pertaining to the Annual General Meeting. 6. General business discussions. |
| 542685 | Digicontent Digicontent Ltd | 19-May-2026 | Audited Results |
| 542905 | Hindware Home In Hindware Home Innovation Ltd | 19-May-2026 | Final Dividend & Audited Results |
| 542907 | Prince Pipes Prince Pipes & Fittings Ltd | 19-May-2026 | Prince Pipes And Fittings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby intimate you that a meeting of the Board of Directors of the Company will be held on Tuesday, May 19, 2026, inter alia, to: - Consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026. - Consider and recommend final dividend, if any on the paid-up equity shares of the Company for the Financial Year 2025-26. Further, kindly note that, under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company has been closed from Wednesday, April 01, 2026, to Thursday, May 21, 2026, i.e 48 hours after the declaration of financial results (both days inclusive). This intimation is also being uploaded on the Company's website at www.princepipes.com. |
| 543212 | Borosil Borosil Ltd | 19-May-2026 | Borosil Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026 and to seek shareholders'' approval (through an enabling resolution) for raising of funds through various modes. |
| 543283 | United Foodbrands United Foodbrands Ltd | 19-May-2026 | Quarterly Results & Audited Results United Foodbrands Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and financial year ended March 31, 2026. (As Per BSE Announcement Dated On : 12.05.2026) |
| 543425 | C.E. Info System C.E. Info Systems Ltd | 19-May-2026 | C.E. Info Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve Intimation for Board Meeting |
| 543482 | Eureka Forbes Eureka Forbes Ltd | 19-May-2026 | Eureka Forbes Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Statements and Results of the Company for the Quarter and Financial Year ended March 31, 2026. |
| 543904 | Mankind Pharma Mankind Pharma Ltd | 19-May-2026 | Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31 2026 and realignment of security cover provided in respect of existing Non-Convertible Debentures. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
